Brazilian Pharmaceutical Company Counters Merck’s Position on Ivermectin Efficacy & Safety for COVID-19
In what can be considered a direct rebuttal to another ivermectin manufacturer in the United States, a Brazilian pharmaceutical manufacturer […]
In what can be considered a direct rebuttal to another ivermectin manufacturer in the United States, a Brazilian pharmaceutical manufacturer […]
Thanks to a story by Dan Herbeck writing for the Buffalo News, TrialSite was able to distribute important information to […]
TrialSite recently introduced the Nigerian-based IVERCOVID study. In an interview with the principal investigator Professor Olufemi Babalola, an ophthalmologist and […]
Back in May 2020, TrialSite announced the study titled a pilot clinical trial led by Egypt’s Mansoura University, located in […]
TrialSite reports to the TSN community a recent World Health Organization (WHO) video from today. The panel was asked by […]
A February 4 press release from Merck is raising yet more questions about why research money is not going to […]
The health authorities in South African have established that the only acceptable use of Ivermectin in the context of COVID-19 […]
The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they consider a pathbreaking “high-quality […]
The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they consider a pathbreaking “high-quality […]
Rodrigo Duterte, the controversial President of the Philippines, hasn’t really embraced, nor even appreciated, the past good relations between the […]